PURE Bioscience, Inc. (PURE) Reports Q4 Loss of $0.05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall Street futures subdued as tech wobbles again; Tesla gains
- Oil heads for weekly gain with focus on Middle East supply
- U.S. producer prices rise by 1.3% month-on-month in September
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Price: $0.07 --0%
Financial Fact:
Loss from operations: -1.45M
Today's EPS Names:
OMID, BCBP, BCML, More
Financial Fact:
Loss from operations: -1.45M
Today's EPS Names:
OMID, BCBP, BCML, More
Join SI Premium – FREE
PURE Bioscience, Inc. (NASDAQ: PURE) reported Q4 EPS of ($0.05), versus ($0.05) reported last year. Revenue for the quarter came in at $244 thousand, versus $324 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prologis (PLD) Tops Q3 EPS by 8c; revises guidance
- Travelers (TRV) Tops Q3 EPS by $1.93, Beats on Revenue
- ManpowerGroup (MAN) Reports In-Line Q3 EPS; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
